Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 98, Issue 5, 2012, Pages

  Lerchbaum, Elisabeth ^a   Schwetz, Verena ^a   Giuliani, Albrecht ^a   Pieber, Thomas R ^a   Obermayer Pietsch, Barbara ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

DHEAS; free testosterone; hyperandrogenemia; metabolic disturbances; polycystic ovary syndrome

Indexed keywords

PRASTERONE SULFATE; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OUTPATIENT DEPARTMENT; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

EID: 84867745536     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.07.1057     Document Type: Article

References (32)

1. E. Diamanti-Kandarakis, C.R. Kouli, A.T. Bergiele, F.A. Filandra, T.C. Tsianateli, and G.G. Spina A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006 4011
2. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline J Clin Endocrinol Metab 91 2006 4237 4245
3. S. Jonard, and D. Dewailly The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest Hum Reprod Update 10 2004 107 117
4. M.J. Chen, W.S. Yang, C.L. Chen, M.Y. Wu, Y.S. Yang, and H.N. Ho The relationship between anti-müllerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome Hum Reprod 23 2008 952 957
5. C.G. Baptiste, M.C. Battista, A. Trottier, and J.P. Billargeon Insulin and hyperandrogenism in women with polycystic ovary syndrome J Steroid Biochem Mol Biol 122 2010 42 52
6. E. Carmine Ovarian and adrenal hyperandrogenism Ann NY Acad Sci 1092 2006 130 137
7. E. Carmina, and R.A. Lobo Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes J Endocrinol Invest 30 2007 111 116
8. A. Kumar, K.S. Woods, A.A. Bartolucci, and R. Azziz Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) Clin Endocrinol 62 2005 644 649
9. C.K. Buffington, J.R. Givens, and A.E. Kitabchi Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity: in vivo and in vitro studies of hyperandrogenic females Diabetes 40 1991 693 700
10. K. Brennan, A. Huang, and R. Azziz Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome Fertil Steril 91 2009 1848 1852
11. E. Wehr, R. Möller, R. Horejsi, A. Giuliani, D. Kopera, and N. Schweighofer Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome Wien Klin Wochenschr 121 2009 262 269
12. H. Schunkert, H.W. Hense, T. Andus, G.A. Riegger, and R.H. Straub Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample Am J Hypertens 12 1999 1140 1143
13. M.J. Chen, C.D. Chen, J.H. Yang, C.L. Chen, H.N. Ho, and W.S. Yang High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome Hum Reprod 26 2011 227 234
14. N. Köşüş, A. Köşüş, Z. Kamalak, D. Hzl, and N.O. Turhan Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome Gynecol Endocrinol 28 2012 611 614
15. Rotterdam ESHRE/ASRM-Sponsored Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
16. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Circulation 106 2002 3143 3421
18. N. Orentreich, J.L. Brind, R.L. Rizer, and J.H. Vogelman Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J Clin Endocrinol Metab 59 1984 551 555
19. G. Paolisso, S. Ammendola, M. Rotondi, A. Gambardella, M.R. Rizzo, and G.T. Mazziotti Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate? Metabolism 46 1997 1281 1286
20. B.R. Walker, A. Rodin, N.F. Taylor, and R.N. Clayton Endogenous inhibitors of 11β-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome Clin Endocrinol 52 2000 77 80
21. T. Tsilchorozidou, J.W. Honour, and G.S. Conway Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5α-reduction but not the elevated adrenal steroid production rates J Clin Endocrinol Metab 88 2003 5907 5913
22. R. Azziz, J.E. Nestler, and D. Dewailly Androgen excess disorders in women 1997 Lippincott-Raven Philadelphia
23. R. Yamashita, T. Saito, S. Satoh, K. Aoki, Y. Kaburagi, and H. Sekihara Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2 Endocr J 52 2005 727 733
24. L. Farah-Eways, R. Reyna, E.S. Knochenhauer, A.A. Bartolucci, and R. Azziz Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome Fertil Steril 81 2004 120 125
25. S. Savastano, A. Belfiore, B. Guida, L. Angrisani, F. Orio Jr., and T. Cascella Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women J Endocrinol Invest 28 2005 509 515
26. W. Kameda, M. Daimon, T. Oizumi, Y. Jimbu, M. Kimura, and A. Hirata Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Funagata study Metabolism 54 2005 669 676
27. F.P. de Heredia, D. Cerezo, S. Zamora, and M. Garaulet Effect of dehydroepiandrosterone on protein and fat digestibility, body protein and muscular composition in high-fat-diet-fed old rats Br J Nutr 97 2007 464 467
28. J. Sánchez, F. Pérez-Heredia, T. Priego, M.P. Portillo, S. Zamora, and M. Garaulet Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity J Nutr Biochem 19 2008 809 818
29. W. Arlt, and B. Allolio Adrenal insufficiency Lancet 361 2003 1881 1893
30. A.J. Morales, J.J. Nolan, J.C. Nelson, and S.S. Yen Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J Clin Endocrinol Metab 78 1994 1360 1367
31. B. Allolio, and W. Arlt DHEA treatment: myth or reality? Trends Endocrinol Metab 13 2002 288 294
32. W. Rosner, H. Vesper Endocrine Society; American Association for Clinical Chemistry; American Association of Clinical Endocrinologists; Androgen Excess/PCOS Society; American Society for Bone and Mineral Research; American Society for Reproductive Medicine; American Urological Association; Association of Public Health Laboratories; Endocrine Society; Laboratory Corporation of America; North American Menopause Society; Pediatric Endocrine Society Toward excellence in testosterone testing: a consensus statement J Clin Endocrinol Metab 95 2010 4542 4548